TY - JOUR
T1 - Reversible inhibition of type B monoamine oxidase. Theoretical study of model diazo heterocylic compounds
AU - Wouters, J.
AU - Ooms, Frédéric
AU - Jegham, S.
AU - Koenig, J. J.
AU - George, P.
AU - Durant, F.
PY - 1997/9/1
Y1 - 1997/9/1
N2 - Different families of heterocycles containing 2 to 4 nitrogen atoms (oxadiazolones, tetrazoles and oxadiazinone derivatives, so-called diazoheterocyclics) are currently used as lead compounds for the design of reversible and selective monoamine oxidase B (MAO-B) inhibitors. In order to clarify the mechanism of interaction of these molecules with the enzyme, we adopted a theoretical approach (ab initio calculations) and studied several structural and electronic properties of prototype molecules of the aryl diazo heterocyclic chemical series. This work provides a theoretical basis for structure-inhibition relationships in chemical series with potential IMAO-B properties.
AB - Different families of heterocycles containing 2 to 4 nitrogen atoms (oxadiazolones, tetrazoles and oxadiazinone derivatives, so-called diazoheterocyclics) are currently used as lead compounds for the design of reversible and selective monoamine oxidase B (MAO-B) inhibitors. In order to clarify the mechanism of interaction of these molecules with the enzyme, we adopted a theoretical approach (ab initio calculations) and studied several structural and electronic properties of prototype molecules of the aryl diazo heterocyclic chemical series. This work provides a theoretical basis for structure-inhibition relationships in chemical series with potential IMAO-B properties.
KW - Ab initio calculation
KW - Model of interaction
KW - Reversible MAO-B inhibition
UR - http://www.scopus.com/inward/record.url?scp=0030863958&partnerID=8YFLogxK
U2 - 10.1016/S0223-5234(97)88914-3
DO - 10.1016/S0223-5234(97)88914-3
M3 - Article
AN - SCOPUS:0030863958
SN - 0223-5234
VL - 32
SP - 721
EP - 730
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
IS - 9
ER -